Nitroprusside bulk supplier for pharma manufacturers

Nitroprusside 50 mg/2 mL vial Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) injection

Available Strengths: 50 mg/2 mL vial

Reference Brands: Nitropress®(US)

Nitroprusside IV is a potent vasodilator for hypertensive crises and acute heart failure. Supplied as a 50 mg/2 mL lyophilized vial, it enables rapid blood pressure control. Pharma B2B platforms offer GMP-grade nitroprusside in bulk for hospitals, ensuring quality, regulatory compliance, and reliable international supply.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Nitroprusside? List it or send an offer →

Product Description: Nitroprusside is a fast-acting vasodilator used in hypertensive emergencies and acute heart failure. Administered via IV infusion, it comes in 50 mg/2 mL vials as a lyophilized powder requiring dilution. Nitroprusside provides immediate blood pressure control by relaxing vascular smooth muscle. Available under brands like Nitropress® in the US and Nitroprussiat Ferrlecit® in the EU, it is widely used in critical care and surgical settings. Pharma B2B marketplaces offer bulk sourcing of GMP-compliant nitroprusside from certified manufacturers, ensuring consistent quality, global regulatory compliance, and secure supply for hospitals, ICUs, and emergency care providers

Nitroprusside — third party manufacturing & bulk supply

Nitroprusside 50 mg/2 mL vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Nitroprusside is supplied as Intravenous (IV) injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Nitroprusside listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Nitroprusside →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Nitroprusside is listed as Intravenous (IV) injection in 50 mg/2 mL vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Nitroprusside is referenced against Nitropress®(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.